Results 201 to 210 of about 5,048,722 (239)

UPDATE ON MUCOPOLYSACCHARIDOSIS TYPE II

Acta Paediatrica, 2007
Michael, Beck, Ed, Wraith
openaire   +2 more sources

Mucopolysaccharidosis type II

Acta Paediatrica, 2007
Froissart, R, Silva, IM, Maire, I
openaire   +3 more sources

Mucopolysaccharidosis II

Seminars in Roentgenology, 1973
openaire   +1 more source

Hunter Syndrome (Mucopolysaccharidosis II)

Pediatric Dermatology, 1990
openaire   +2 more sources

Newborn screening for mucopolysaccharidosis type II

Molecular Genetics and Metabolism, 2023
Barbara K. Burton, Vera P. Shively, Allegra M. Quadri, Jennifer E. Burton, Katherine Christensen, Dorothy K. Grange, Daniel Groepper, Lauren Warn, Joan Ehrhardt, Laura Ashbaugh, Khaja Basheeruddin   +10 more
openaire   +1 more source

Mucopolysaccharidosis type II, Hunter's syndrome.

Pediatric endocrinology reviews : PER, 2014
Hunter syndrome is caused by deficiency of the lysososmal enzyme iduronate-2-sulphatase that cleaves O-linked sulphate moieties from dermatan sulphate and heparan sulphate and leads to accumulation of GAGs. The disease is a X-linked condition affecting males and rarely females, clinically divided into severe (2/3) and attenuated types.
openaire   +1 more source

The efficacy of intracerebroventricular idursulfase-beta enzyme replacement therapy in mucopolysaccharidosis II murine model: heparan sulfate in cerebrospinal fluid as a clinical biomarker of neuropathology

Journal of Inherited Metabolic Disease, 2018
Y. Sohn, A. Ko, Mi-ran Seong, Soyeon Lee, Mi Ra Kim, S. Cho, Jung-Sun Kim, M. Sakaguchi, T. Nakazawa, M. Kosuga, Joo-Hyun Seo, T. Okuyama, D. Jin   +12 more
semanticscholar   +1 more source

Anesthesia for an adult with mucopolysaccharidosis I

Journal of Clinical Anesthesia, 2005
John L Ard
exaly  

Mucopolysaccharidosis II

2012
openaire   +1 more source

Outcomes of Long-Term Treatment with Laronidase in Patients with Mucopolysaccharidosis Type I

Journal of Pediatrics, 2016
Jane Ashworth, Simon A Jones
exaly